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Etofenamate and anastomoses of the colon in rats
Aim: Non-steroidal anti-inflammatory drugs have been used for many years due to their analgesic
and anti-inflammatory properties. They have also been used for postoperative analgesia. We aimed
to study the effects of etofenamate, a non-steroidal anti-inflammatory drug, on the healing of colonic
anastomoses in rats.
Materials and methods: Sprague-Dawley rats were used in this study. Resection and anastomosis
were performed on the distal colon. The etofenamate group received 30 mg/kg etofenamate and the
control group received 0.1 mL of 0.9% NaCl intramuscularly daily. Bursting pressures of anastomoses
and hydroxyproline levels of perianastomotic tissues were determined on days 3 and 7.
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Results: Four deaths were observed in each group. Mean bursting pressures (etofenamate group, day
3: 50.50 ± 7.27 mmHg, day 7: 187.37 ± 12.20 mmHg; control group, day 3: 55.13 ± 5.94 mmHg, day
7: 202.12 ± 18.64 mmHg) and mean hydroxyproline levels (etofenamate group, day 3: 2.18 ± 0.17
μg/mg tissue, day 7: 4.34 ± 0.79 μg/mg tissue; control group, day 3: 2.20 ± 0.12 μg/mg tissue, day 7:
5.07 ± 0.65 μg/mg tissue) in the etofenamate group were lower than those in the control group on
both days 3 and 7. This finding was not statistically significant.
Conclusion: According to our findings, etofenamate treatment during the postoperative period does
not alter the healing of colonic anastomoses in rats.
Key words: Non-steroidal anti-inflammatory drugs, etofenamate, colon, anastomosis, healing, rat

Etofenamate’ın rat kolon anastomozuna etkisi
Amaç: Nonsteroid antinflamatuar ilaçlar, analjezik ve antiinflamatuar olarak yıllardır
kullanılmaktadırlar. Ayrıca postoperatif ağrı tedavisinde de kullanılan ilaçlardır. Çalışmamızda bir
nonsteroid antiinflamatuar ilaç olan etofenamate’ın ratlarda kolon anastomozu iyileşmesi üzerine
etkilerini araştırdık.
Yöntem ve gereçler: Çalışmada Sprague-Dawley ratlar kullanıldı. Ratların distal kolonlarında
rezeksiyon yapılarak anastomoz gerçekleştirildi. Etofenamate grubu’ndaki ratlara 30 mg/kg/gün
etofenamate, kontrol grubu’ndaki ratlara ise 0,1 mL/gün % 0,9 NaCl intramüsküler uygulandı.
Üçüncü ve yedinci günlerde anastomozların patlama basınçları ve anastomoz etrafındaki dokuların
hidroksiprolin düzeyleri ölçüldü.
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Bulgular: Her iki gruptan da dörder rat kaybedildi. Ortalama patlama basınçları (etofenamate grubu,
3. gün: 50,50 ± 7,27, 7. gün: 187,37 ± 12,20, kontrol grubu, 3. gün: 55,13 ± 5,94, 7. gün: 202,12 ±
18,64 mmHg) ve ortalama hidroksiprolin düzeyleri (etofenamate grubu, 3. gün: 2,18 ± 0,17, 7. gün:
4,34 ± 0,79, kontrol grubu, 3. gün: 2,20 ± 0,12, 7. gün: 5,07 ± 0,65 μg/mg doku) etofenamate grubu’nda
kontrol grubu’na göre daha düşük bulundu. Bu bulgular istatistiksel olarak anlamlı değildi.
Sonuç: Postoperatif dönemde etofenamate kullanılmasının ratlarda kolon anastomoz iyileşmesine
olumsuz etkisi gözlenmemiştir.
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Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) have been used for many
years for analgesic, anti-inflammatory, and antithrombotic purposes and have
become one of the most commonly used medications. Their perisurgical use has
increased (1-3). NSAIDs are generally well tolerated (1). The action of NSAIDs is
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based on the inhibition of cyclo-oxygenase, which
converts the arachidonic acid that is set free from the
cell wall into prostaglandins, prostacyclin, and
thromboxane (4).
Etofenamate is a long-acting NSAID and rapidacting intramuscular analgesic. Etofenamate has
effects on pain similar to those of fentanyl and can be
used safely (5).
Resection and anastomosis of the colon are
associated with a high incidence of anastomotic
leakage ranging between 0% and 35% (6,7). When this
serious complication occurs, morbidity and mortality
rates and the hospital length of stay greatly increase
after colonic surgery (8). Many factors may
compromise the healing of colonic anastomoses (7,9).
Contradictory reports exist concerning the role of
anti-inflammatory drugs in wound healing (3).
As the perisurgical use of NSAIDs has increased
we studied anastomotic healing in the colon of rats
treated with etofenamate during the postoperative
period. We examined the bursting pressures of
anastomoses and hydroxyproline contents of
perianastomotic tissues.
Materials and methods
The Ethical Committee of Fatih University
Medical School approved the methodology of this
experimental study.
Forty male Sprague-Dawley rats (240-280 g) were
used. A biostatistician was consulted to determine the
number of rats. The animals had free access to normal
laboratory food (Medaş, Ankara) and tap water. They
were housed at 21 °C and 12 h light-dark cycle.
On the day of surgery, anaesthesia was maintained
with ketamine (Ketalar, Eczacıbaşı) 30 mg/kg,
intramuscularly. After shaving, the abdomen was
prepared with povidone-iodine. Surgery was
performed under sterile conditions through a lower
midline 2 cm abdominal laparotomy; 0.5 cm of the
colon was resected 3 cm proximal to the peritoneal
reflection. The mesenteric arcade was protected
during the resection. Anastomosis was performed in
a single layer with 9-12 interrupted inverting 6/0
polypropylene sutures (Prolone, Ethicon). The
abdomen was closed with 3/0 polyglactine (Polysorb,
Tyco) running sutures in 2 layers.
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The rats divided into 2 groups randomly. The
etofenamate group (EG) received 30 mg/kg
etofenamate daily (Flexo ampul, Santa Farma) and the
control group (CG) received 0.1 mL/day 0.9% NaCl
intramuscular. On the third postoperative day, 8 rats
from each group were randomly selected for
measurement
of
bursting
pressure
and
hydroxyproline level in the perianastomotic region.
Anaesthesia was maintained with ketamine 30 mg/kg.
The whole colon was resected. Great attention was
paid not to break the adhesions of the
perianastomotic region. The rats were sacrificed by
cardiac puncture.
Colonic anastomoses can be measured using
bursting pressure and collagen concentration (7,10).
We used these 2 measures to evaluate anastomotic
healing.
The proximal end of the colon was attached to an
air pump supplying 1 mL of air per minute. The distal
end was attached to a continuous pressure display
system (Petaş KMA365B). The colon was immersed
into saline. The air pump started. The pressure was
recorded as “bursting pressure” when the pressure
went down suddenly or bubbles were seen. The
perianastomotic region was cleared after bursting. A
colon segment of 1 cm (0.5 cm each side of
anastomosis) was taken and rinsed with saline for
hydroxyproline determination.
The samples were stored at -40 °C for subsequent
analysis of hydroxyproline content of the
perianastomotic region.
Determination of hydroxyproline level was
performed as described by Jamall et al. (11).
Hydroxyproline was released from colon tissue
homogenates using acid hydrolysis. The free
hydroxyproline was then oxidised by chloramine to
produce a pyrrole-type compound. The addition of
Ehrlich's reagent resulted in the formation of a
chromophore measured at 560 nm. The absorbances
were read using distilled water as reference and the
results were given as μg/mg tissue.
Other rats from each group underwent the same
procedure on day 7.
SPSS for Windows 10.0 was used for the statistical
analysis. A Mann-Whitney U test was used to
determine differences in the groups. The statistical
significance level was set at P < 0.05.
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Results
Four deaths were observed in each group. Three
rats on day 3, 2 rats on day 4, and 3 rats on day 5 of
surgery died because of septic complications due to
anastomotic leakage. The other rats survived until the
end of the study without any septic, surgical, or
anaesthetic complications. There was no statistical
difference in the groups in terms of mortality (P >
0.05).
Mean bursting pressure in the etofenamate group
was lower than that in the control group on both days
3 and 7. This finding was not statistically significant
(Table 1).
Mean hydroxyproline content in the etofenamate
group was also lower than that in the control group
on both days 3 and 7. This finding was not statistically
significant either (Table 2).
Discussion
NSAIDs are a commonly used class of medication
and have a broad spectrum of clinical applications
including perioperative pain (12,13). Perioperative
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use of NSAIDs reduces postoperative pain and opioid
consumption (14). The use of these drugs continues to
increase (2). They have anti-inflammatory as well as
analgesic, antipyretic, and platelet inhibitory actions
(15).
The pharmacologic activity of NSAIDs is
attributed to inhibition of cyclooxygenase enzymes.
Cyclooxygenases catalyse the first step of the synthesis
of prostanoids (16).
It is reported that inhibition of cyclooxygenase
significantly affects the healing of sutured surgical
incisions in mouse skin (17).
Anastomotic healing requires many complex
processes and factors. A number of interactions have
been identified as having a profound effect on healing.
Many components of the healing process are common
to all tissues as anastomotic healing. Initially
inflammatory response includes infiltration and
capillary ingrowth; then early collagenolysis takes
place. The proliferative phase is characterised by
proliferation of fibroblasts, which synthesise collagen
in the submucosal layer. Collagen is the major protein
of the extracellular matrix and the predominant

Table 1. Mean bursting pressures of groups.
Day

Group

Number of rats

Bursting pressure
(Mean ± SD mmHg)

Control

8

55.13 ± 5.94

Etofenamate

8

50.50 ± 7.27

Control

8

202.12 ± 18.64

Etofenamate

8

187.37 ± 12.20

3

P value

0.154

7

0.141

Table 2. Mean hydroxyproline contents of groups.
Day

Group

Number of rats

Hydroxyproline Content
(Mean ± SD μg/mg tissue)

Control

8

2.20 ± 0.12

Etofenamate

8

2.18 ± 0.17

Control

8

5.07 ± 0.65

Etofenamate

8

4.34 ± 0.79

3

P value

0.494

7

0.052
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constituent of the final healing scar. Collagen
continues to form and remodel via cross-linking
during the maturative phase. This results in the
formation of mature scar tissue (8,9,18,19). Cellular
activities for wound healing include migration,
phagocytosis, chemotaxis, adhesion, mitogenesis, and
synthesis of matrix components (19).
NSAIDs delay the onset of fibroblast proliferation
(20). This influences the proliferative phase of healing
negatively.
Prostaglandins and thromboxane are involved in
inflammatory processes, but their conversion from
arachidonic acid is inhibited by NSAIDs, which may
have a negative influence on the inflammation. As an
adequate inflammatory reaction is essential for
healing, drugs interfering with the inflammatory
phase like NSAIDs probably modify anastomotic
healing (3,17).
Polymorphonuclear leukocytes are the first cell
type to accumulate in inflammatory reactions. It has
been shown that NSAIDs can inhibit
polymorphonuclear leucocyte responses such as the
extracellular release of lysosomal enzymes,
chemotaxis, migration, aggregation, adherence and
spontaneous motility, and the production of
superoxide anion (21,22). These effects of NSAIDs
may be independent of their inhibition of
prostaglandin synthesis (21). Cyclooxygenase
inhibition increases histamine levels, which may be
also inhibitory for leukocyte mobility (22). However,
in the inflammatory phase of the healing process of
anastomosis, neutrophils play an important role by
clearing up debris, protecting from infection, and
releasing growth-promoting substances (23,24).
Decreased neutrophil infiltration coincides with
defective anastomotic healing in rats (23).
A number of NSAIDs inhibit the expression and
release of cytokines in activated human monocytes,
namely IL-1β, TNFα, and IL-6, and chemokines such
as IL-8. The mechanism by which cytokine expression
is inhibited by NSAIDs is not clear (15). Inhibition of
these substances has a negative influence on the
healing because IL-1β and TNFα function in matrix
synthesis regulation and cell recruitment and
activation. TNFα also functions in neutrophyl
activation and angiogenesis. IL-6 functions in cell
recruitment and activation (24).
716
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NSAIDs can inhibit superoxide anion generation
(25), but decreased production of oxygen-derived free
radicals may negatively affect the healing of
anastomoses with a higher incidence of abscess
formation (18), because superoxide anions play a role
in phagocytosis and antimicrobial function (24).
Angiogenesis is required in the healing phase of a
colorectal anastomosis (26,27). Adequate tissue
perfusion and oxygen delivery are necessary for good
anastomotic healing (28). Prostaglandins may
modulate fibroblast growth factor β and vascular
endothelial growth factor induced angiogenesis.
Cyclooxygenase inhibitors have been shown to block
angiogenesis in vitro and in vivo in the rat cornea, rat
air pouch model, and in mouse tumour models (17).
Some NSAIDs have a distinct inhibitory effect on
protein synthesis, which may influence the healing
negatively (29).
Bursting pressure of an anastomosis is a
mechanical parameter of the healing of the
anastomosis (6,23). Hydroxyproline content of the
perianastomotic tissue is a measure of the amount of
collagen (6,30). According to our findings, bursting
pressures and hydroxyproline contents of etofenamate
treated rats did not differ from those of the controls.
There are contradictory reports of the effects of
NSAIDs on the healing of wounds (3,13,17,20). In a
study by Quirinia and Viidik influences of diclofenac
and indomethacin on the healing of normal and
ischemic incisional wounds are investigated. They
found that neither of these 2 NSAIDs had an influence
on healing (13). Dvivedi et al. reported that ibuprofen
and diclofenac sodium caused a reduction in the
strength of wound and the weight of granuloma
formed (3). Blomme et al. reported chronic daily
treatment with selective cyclooxygenase-2 inhibitor
or diclofenac had no significant effect on cutaneous
healing (17). In another experimental study, Sousa et
al. investigated the effects of diclofenac sodium on
intestinal anastomotic healing and found that it had a
negative effect (20).
In conclusion, NSAIDs have some properties that
may have negative effects on the healing of wounds,
like a negative influence on inflammation, inhibition
of polymorphonuclear leucocyte responses, inhibition
of cytokine release and expression, inhibition of
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superoxide anion generation, blocking angiogenesis,
and inhibitory effect on protein synthesis. Despite the
reported effects of NSAIDs on the healing of wounds,
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on the basis of the present results etofenamate
treatment during the postoperative period does not
alter the healing of colonic anastomoses in rats.
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